Toth CA, Morse LS, Hjelmeland LM, Landers MB 3rd. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol. 1991;109(5):723–9.

Article  PubMed  CAS  Google Scholar 

Coll GE, Sparrow JR, Marinovic A, Chang S. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage. Retina. 1995;15(4):319–26.

Article  PubMed  CAS  Google Scholar 

Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213(2):97–102.

Article  PubMed  CAS  Google Scholar 

Glatt H, Machemer R. Experimental Subretinal Hemorrhage in Rabbits. Am J Ophthalmol. 1982;94(6):762–73.

Article  PubMed  CAS  Google Scholar 

Inoue N, Kato A, Araki T, Kimura T, Kinoshita T, Okamoto F, Murakami T, Mitamura Y, Sakamoto T, Miki A, et al. Visual prognosis of submacular hemorrhage secondary to age-related macular degeneration: A retrospective multicenter survey. PLoS ONE. 2022;17(7): e0271447.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mun Y, Park KH, Park SJ, Cho HJ, Kim CG, Kim JW, Park DG, Sagong M, Kim JH, Woo SJ. Comparison of treatment methods for submacular hemorrhage in neovascular age-related macular degeneration: conservative versus active surgical strategy. Sci Rep. 2022;12(1):14875.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jain S, Kishore K, Sharma YR. Intravitreal anti-VEGF monotherapy for thick submacular hemorrhage of less than 1 week duration secondary to neovascular age-related macular degeneration. Indian J Ophthalmol. 2013;61(9):490–6.

Article  PubMed  PubMed Central  Google Scholar 

Berrocal MH, Lewis ML, Flynn HW Jr. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol. 1996;122(4):486–93.

Article  PubMed  CAS  Google Scholar 

Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, Mahmoud TH. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience. Ophthalmology Retina. 2018;2(3):180–6.

Article  PubMed  Google Scholar 

Barayev E, Tiosano A, Zlatkin R, Elul R, Dotan A, Hadayer A, Gal-Or O, Ehrlich R. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration. Eur J Ophthalmol. 2024;34(3):825–33. https://doi.org/10.1177/11206721231202048.

Motta L, Ripa M, Theodoraki K, Jackson TL, McHugh D. A Case of Traumatic Submacular Hemorrhage Treated with tPA and Pneumatic Displacement. Case Rep Ophthalmol. 2023;14(1):596–601.

Article  PubMed  PubMed Central  Google Scholar 

Novelli FJ, Preti RC, Monteiro ML, Nóbrega MJ, Takahashi WY. A new method of subretinal injection of tissue plasminogen activator and air in patients with submacular hemorrhage. Retina (Philadelphia, Pa). 2017;37(8):1607.

Article  PubMed  Google Scholar 

Abdulaal M, Donkor R, Robertson J, Lewis S, Miller DG, Schartman J, Platt S, Coney JM. Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes. Can J Ophthalmol. 2024;59(5):e582-9. https://doi.org/10.1016/j.jcjo.2023.10.005.

Patikulsila D, Winaikosol P, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, Kunavisarut P. Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series. BMC Ophthalmol. 2022;22(1):411.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Limon U, Gezginaslan TA, Saygin IO, Bozkurt E, Kardes E, Akcay BIS. Efficacy of Simultaneous Application of Subretinal Tissue Plasminogen Activator and Bevacizumab for Submacular Hemorrhages. Beyoglu Eye J. 2023;8(3):198–207.

Article  PubMed  PubMed Central  Google Scholar 

Hirashima T, Moriya T, Bun T, Utsumi T, Hirose M, Oh H. Optical coherence tomography findings and surgical outcomes of tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage secondary to age-related macular degeneration. Retina. 2015;35(10):1969–78.

Article  PubMed  CAS  Google Scholar 

Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review. Int Ophthalmol. 2021;41(12):4037–46.

Article  PubMed  Google Scholar 

Sniatecki JJ, Ho-Yen G, Clarke B, Barbara R, Lash S, Papathomas T, Antonakis S, Gupta B. Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration. Eur J Ophthalmol. 2021;31(2):643–8.

Article  PubMed  Google Scholar 

Moussa G, Bassilious K, Mathews N. A novel excel sheet conversion tool from Snellen fraction to LogMAR including ‘counting fingers’, ‘hand movement’, ‘light perception’ and ‘no light perception’ and focused review of literature of low visual acuity reference values. Acta Ophthalmol. 2021;99(6):e963–5.

Article  PubMed  Google Scholar 

Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC. Management of Thick Submacular Hemorrhage With Subretinal Tissue Plasminogen Activator and Pneumatic Displacement for Age-Related Macular Degeneration. Am J Ophthalmol. 2014;157(6):1250–7.

Article  PubMed  CAS  Google Scholar 

Yiu G, Mahmoud TH. Subretinal hemorrhage. Dev Ophthalmol. 2014;54:213–22.

Article  PubMed  Google Scholar 

Gabrielle PH, Delyfer MN, Glacet-Bernard A, Conart JB, Uzzan J, Kodjikian L, Arndt C, Tadayoni R, Soudry-Faure A, Creuzot Garcher CP. Surgery, Tissue Plasminogen Activator, Antiangiogenic Agents, and Age-Related Macular Degeneration Study: A Randomized Controlled Trial for Submacular Hemorrhage Secondary to Age-Related Macular Degeneration. Ophthalmology. 2023;130(9):947–57.

Article  PubMed  Google Scholar 

He X, Cao W, Wang Z, Zhang N, Xu K, Yu L, Xing Y, Yang N. Efficacy Evaluation of Tissue Plasminogen Activator with Anti-Vascular Endothelial Growth Factor Drugs for Submacular Hemorrhage Treatment: A Meta-Analysis. J Clin Med. 2023;12(3):1035. https://doi.org/10.3390/jcm12031035.

Boral SK, Agarwal D, Das A, Chakraborty D, Mandal S. Real-world outcomes and complications of different surgical approaches for significant submacular haemorrhages. Indian J Ophthalmol. 2023;71(5):2045–52.

Article  PubMed  PubMed Central  Google Scholar 

Oncel D, Oncel D, Mishra K, Oncel M, Arevalo JF. Current Management of Subretinal Hemorrhage in Neovascular Age-Related Macular Degeneration. Ophthalmologica. 2023;246(5–6):295–305.

Article  PubMed  Google Scholar 

Hawkins BS, Bressler NM, Miskala PH, Bressler SB, Holekamp NM, Marsh MJ, Redford M, Schwartz SD, Sternberg P Jr, Thomas MA, et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: ophthalmic findings: SST report no. 11. Ophthalmology. 2004;111(11):1967–80.

Article  PubMed  Google Scholar 

Kallstrand J, Lindgren EC, Carlsson IM. Perpetuating ability to live life as usual: a grounded theory study of persons living with age-related macular degeneration. BMC Geriatr. 2024;24(1):82.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch Clin Exp Ophthalmol. 2010;248(1):5–11.

Article  PubMed  CAS  Google Scholar 

Driscoll S, Garg S. Managing submacular hemorrhage. Rev Ophthalmol. 2014:40–45.

Uyama M, Matsubara T, Fukushima I, Matsunaga H, Iwashita K, Nagai Y, Takahashi K. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol. 1999;117(8):1035–42.

Article  PubMed  CAS  Google Scholar 

McCabe CM, Flynn HW Jr, McLean WC, Brod RD, McDonald HR, Johnson MW, Williams GA, Mieler WF. Nonsurgical management of macular hemorrhage secondary to retinal artery macroaneurysms. Arch Ophthalmol. 2000;118(6):780–5.

Article  PubMed  CAS  Google Scholar